FBTAX
Price
$28.38
Change
-$0.19 (-0.67%)
Updated
Aug 7 closing price
Net Assets
1.4B
LYFIX
Price
$12.14
Change
-$0.03 (-0.25%)
Updated
Aug 7 closing price
Net Assets
32.17M
Interact to see
Advertisement

FBTAX vs LYFIX

Header iconFBTAX vs LYFIX Comparison
Open Charts FBTAX vs LYFIXBanner chart's image
Fidelity Advisor Biotechnology A
Price$28.38
Change-$0.19 (-0.67%)
VolumeN/A
Net Assets1.4B
AlphaCentric Life Sciences & Hlthcare I
Price$12.14
Change-$0.03 (-0.25%)
VolumeN/A
Net Assets32.17M
FBTAX vs LYFIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FBTAX vs. LYFIX commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FBTAX is a Buy and LYFIX is a StrongSell.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FBTAX has more cash in the bank: 1.4B vs. LYFIX (32.2M). FBTAX pays higher dividends than LYFIX: FBTAX (2.74) vs LYFIX (2.34). FBTAX was incepted earlier than LYFIX: FBTAX (25 years) vs LYFIX (6 years). LYFIX (1.66) is less costly to investors than FBTAX (0.96). LYFIX is a more actively managed with annual turnover of: 164.00 vs. FBTAX (73.00). FBTAX has a lower initial minimum investment than LYFIX: FBTAX (0) vs LYFIX (2500). LYFIX (-3.53) and FBTAX (-3.57) have marching annual gain over last year. LYFIX return over 5 years is better than : 11.83 vs. FBTAX (-4.65).
FBTAXLYFIXFBTAX / LYFIX
Total Expense Ratio0.961.4168%
Annual Report Gross Expense Ratio0.961.6658%
Fund Existence25 years6 years-
Gain YTD4.998-3.566-140%
Front Load6%N/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets1.4B32.2M4,345%
Annual Yield % from dividends2.742.34117%
Returns for 1 year-3.57-3.53101%
Returns for 3 years17.81-8.43-211%
Returns for 5 years-4.6511.83-39%
Returns for 10 years-1.16N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VODPF1.11N/A
N/A
Vodafone Group Plc
GENPF0.01N/A
N/A
GENIX PHARMACEUTICALS CORP.
CTRNF0.16N/A
N/A
CHAR TECHNOLOGIES LTD
BYCRF56.33N/A
N/A
Baycurrent Consulting Inc.
FLTLF28.97-0.15
-0.52%
FLOW TRADERS LTD.